Development of a dual nanocarrier system as a potential stratagem against amyloid-induced toxicity
Author:
Publisher
Informa Healthcare
Subject
Pharmaceutical Science
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425247.2014.912211
Reference35 articles.
1. Recent developments in Alzheimer's disease therapeutics
2. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives
3. The Alzheimer's Amyloid-β(1–42) Peptide Forms Off-Pathway Oligomers and Fibrils That Are Distinguished Structurally by Intermolecular Organization
4. Drug development for Alzheimer's disease: Where are we now and where are we headed?
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer’s Diseases;ACS Applied Bio Materials;2024-05-20
2. Liposomes as carrier for drug delivery in Alzheimer's disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024
3. Potential applications of mesoporous silica nanoparticles for the treatment of neurological disorders;Journal of Drug Delivery Science and Technology;2023-11
4. Gold nanostructure-mediated delivery of anticancer agents: Biomedical applications, reversing drug resistance, and stimuli-responsive nanocarriers;Environmental Research;2023-05
5. Phytosome for Targeted Delivery of Natural Compounds: Improving Efficacy, Bioavailability, and Delivery across BBB for the Treatment of Alzheimer's Disease;Frontiers in Clinical Drug Research - CNS and Neurological Disorders;2023-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3